Related references
Note: Only part of the references are listed.Prognostic implications of RB1 tumour suppressor gene alterations in the clinical outcome of human osteosarcoma: a meta-analysis
W. Ren et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma
Shiyong Li et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
A gene expression signature of Retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer
Luca Malorni et al.
ONCOTARGET (2016)
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine
Andrea Garofalo et al.
GENOME MEDICINE (2016)
Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine
Masayuki Nagahashi et al.
GENOME MEDICINE (2016)
Thoracic and cardiovascular surgery in Japan during 2014 Annual report by The Japanese Association for Thoracic Surgery
Munetaka Masuda et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2016)
Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer
M. Takeda et al.
ANNALS OF ONCOLOGY (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer
Kosj Yamoah et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer
Takashi Kohno et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2015)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
New Targetable Oncogenes in Non-Small-Cell Lung Cancer
Geoffrey R. Oxnard et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Association of Copy Number Loss of CDKN2B and PTCH1 With Poor Overall Survival in Patients With Pulmonary Squamous Cell Carcinoma
Yushi Zhao et al.
CLINICAL LUNG CANCER (2011)
Cyclin D as a therapeutic target in cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2011)
Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer
Eunice L. Kwak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma
I Yoshino et al.
ANNALS OF THORACIC SURGERY (2006)
Genome-wide screening of genomic alterations and their clinicopathologic implications in non-small cell lung cancers
TM Kim et al.
CLINICAL CANCER RESEARCH (2005)
Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials
DW Bell et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic value of smoking status in operated non-small cell lung cancer
PS Nia et al.
LUNG CANCER (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
